GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Joel Greenblatt’s New Magic Formula Stocks: IDCC, SNDK, MHP, OSK, LO, MRX, MSFT, IPXL, CECO, FRX, LPS

gurufocus

gurufocus

341 followers
Joel Greenblatt has not filed his quarterly holdings for the last year. Now he started to file again. As of 12/31/2010, Gotham Capital owns 358 stocks with a total value of $306 million. These are the details of the buys and sells.

With 358 stocks in his portfolio, and the top positions is just above 2% of the total portfolio, we believe that these are the magic formula stocks Joel Greenblatt bought.

If you are not familiar to Magic Formula, please read his book, “The Little Book That Beat the Market”. The formula screens stocks that have high return on capital and earning yield.

This is the portfolio chart of Joel Greenblatt. You can click on the legend of the chart to show/hide buys, sells, or holdings. Each ball on the chart represents a position in the portfolio. You can move your mouse on the balls to see the details of each position and click to see the details of all guru trades with this position.



This is the sector weightings of his portfolio:

Technology 22.1%
Industrials 21.1%
Consumer Services 19.8%
Health Care 19.6%
Consumer Goods 9.2%
Basic Materials 1.5%
Oil & Gas 1%
Financials 0.9%
Telecommunications 0.8%
Utilities 0.5%


These are the top 5 holdings of Joel Greenblatt

  1. InterDigital Inc. (IDCC) - 178,979 shares, 2.44% of the total portfolio. Shares added by 10000%
  2. SanDisk Corp. (SNDK) - 145,474 shares, 2.37% of the total portfolio. Shares added by 10000%
  3. MCGRAWHILL COMPANIES INC (MHP) - 177,470 shares, 2.12% of the total portfolio. Shares added by 10000%
  4. OSHKOSH CORP. (OSK) - 176,158 shares, 2.03% of the total portfolio. Shares added by 10000%
  5. LORILLARD INC. (LO) - 73,499 shares, 1.97% of the total portfolio. Shares added by 10000%


New Purchase: Interdigital Inc. (IDCC)

Joel Greenblatt initiated holdings in Interdigital Inc.. His purchase prices were between $29.35 and $42.82, with an estimated average price of $34.6. The impact to his portfolio due to this purchase was 2.44%. His holdings were 178,979 shares as of 12/31/2010.

INTERDIGITAL COMMUNICATIONS develops and markets advanced digital wireless telecommunications systems using proprietary technologies for voice and data communications and has developed an extensive patent portfolio related to those technologies. Interdigital Inc. has a market cap of $2.58 billion; its shares were traded at around $58.25 with a P/E ratio of 17.8 and P/S ratio of 8.7. The dividend yield of Interdigital Inc. stocks is 0.7%.

New Purchase: Sandisk Corp. (SNDK)

Joel Greenblatt initiated holdings in Sandisk Corp.. His purchase prices were between $36.28 and $51.64, with an estimated average price of $42.79. The impact to his portfolio due to this purchase was 2.37%. His holdings were 145,474 shares as of 12/31/2010.

Sandisk Corporation designs, manufactures, and markets flash memory storage products that are used in a wide variety of electronic systems. Sandisk Corp. has a market cap of $12.13 billion; its shares were traded at around $51.74 with a P/E ratio of 12 and P/S ratio of 2.5.

New Purchase: Mcgrawhill Companies Inc (MHP)

Joel Greenblatt initiated holdings in Mcgrawhill Companies Inc. His purchase prices were between $32.97 and $39.31, with an estimated average price of $35.98. The impact to his portfolio due to this purchase was 2.12%. His holdings were 177,470 shares as of 12/31/2010.

McGraw-Hill Companies Inc. serves business, professional andeducational markets around the world with information products and services. Mcgrawhill Companies Inc has a market cap of $11.74 billion; its shares were traded at around $38.23 with a P/E ratio of 14.2 and P/S ratio of 1.9. The dividend yield of Mcgrawhill Companies Inc stocks is 2.5%. Mcgrawhill Companies Inc had an annual average earning growth of 8.4% over the past 10 years. GuruFocus rated Mcgrawhill Companies Inc the business predictability rank of 4.5-star.

New Purchase: Oshkosh Corp. (OSK)

Joel Greenblatt initiated holdings in Oshkosh Corp.. His purchase prices were between $27.68 and $35.62, with an estimated average price of $31.34. The impact to his portfolio due to this purchase was 2.03%. His holdings were 176,158 shares as of 12/31/2010.

Oshkosh Corporation is a designer, manufacturer and marketer of a broad range of specialty access equipment, commercial, fire & emergency and military vehicles and vehicle bodies. Oshkosh Corp. has a market cap of $3.49 billion; its shares were traded at around $38.41 with a P/E ratio of 4.8 and P/S ratio of 0.4.

New Purchase: Lorillard Inc. (LO)

Joel Greenblatt initiated holdings in Lorillard Inc.. His purchase prices were between $78.7 and $89.22, with an estimated average price of $83.6. The impact to his portfolio due to this purchase was 1.97%. His holdings were 73,499 shares as of 12/31/2010.

LORILLARD is the third largest manufacturer of cigarettes in the United States. Lorillard Inc. has a market cap of $11.85 billion; its shares were traded at around $79.19 with a P/E ratio of 11.7 and P/S ratio of 2. The dividend yield of Lorillard Inc. stocks is 5.7%.

New Purchase: Medicis Pharmaceutical (MRX)

Joel Greenblatt initiated holdings in Medicis Pharmaceutical. His purchase prices were between $26.35 and $30.79, with an estimated average price of $28.49. The impact to his portfolio due to this purchase was 1.89%. His holdings were 215,967 shares as of 12/31/2010.

Medicis is an independent pharmaceutical company focusing exclusively on the treatment of dermatological conditions. Medicis Pharmaceutical has a market cap of $1.74 billion; its shares were traded at around $28.62 with a P/E ratio of 12 and P/S ratio of 3. The dividend yield of Medicis Pharmaceutical stocks is 0.9%.

New Purchase: Microsoft Corp. (MSFT)

Joel Greenblatt initiated holdings in Microsoft Corp.. His purchase prices were between $23.91 and $28.3, with an estimated average price of $26.33. The impact to his portfolio due to this purchase was 1.79%. His holdings were 196,274 shares as of 12/31/2010.

Microsoft develops, manufactures, licenses, and supports a wide range of software products for a multitude of computing devices. Microsoft Corp. has a market cap of $232.8 billion; its shares were traded at around $27.21 with a P/E ratio of 11.6 and P/S ratio of 3.7. The dividend yield of Microsoft Corp. stocks is 2.4%. Microsoft Corp. had an annual average earning growth of 12.6% over the past 10 years. GuruFocus rated Microsoft Corp. the business predictability rank of 3-star.

New Purchase: Impax Laboratories Inc. (IPXL)

Joel Greenblatt initiated holdings in Impax Laboratories Inc.. His purchase prices were between $17.91 and $21.86, with an estimated average price of $19.9. The impact to his portfolio due to this purchase was 1.7%. His holdings were 258,801 shares as of 12/31/2010.

Impax Laboratories, Inc. is a technology-based, specialty pharmaceutical company engaged in the development, manufacture, and marketing of specialty prescription pharmaceutical products utilizing its own formulation expertise and drug delivery technologies. Impax Laboratories Inc. has a market cap of $1.49 billion; its shares were traded at around $23.25 with a P/E ratio of 6.8 and P/S ratio of 4.2.

New Purchase: Career Education Corp. (CECO)

Joel Greenblatt initiated holdings in Career Education Corp.. His purchase prices were between $16.9 and $21.01, with an estimated average price of $18.85. The impact to his portfolio due to this purchase was 1.7%. His holdings were 250,231 shares as of 12/31/2010.

Career Education Corporation is a provider of private, for-profit post-secondary education with campuses throughout the United States and Canada, the United Kingdom and the United Arab Emirates. Career Education Corp. has a market cap of $1.9 billion; its shares were traded at around $23.33 with a P/E ratio of 8.2 and P/S ratio of 1. Career Education Corp. had an annual average earning growth of 12.8% over the past 10 years.

New Purchase: Forest Laboratories Inc. (FRX)

Joel Greenblatt initiated holdings in Forest Laboratories Inc.. His purchase prices were between $30.77 and $33.97, with an estimated average price of $32.65. The impact to his portfolio due to this purchase was 1.7%. His holdings were 162,508 shares as of 12/31/2010.

Forest Laboratories, Inc. and its subsidiaries develop, manufacture and sell both branded and generic forms of ethical drug products which require a physician's prescription, as well as non-prescription pharmaceuticalproducts sold over-the-counter. Forest Laboratories Inc. has a market cap of $9.79 billion; its shares were traded at around $34.26 with a P/E ratio of 8.3 and P/S ratio of 2.3. Forest Laboratories Inc. had an annual average earning growth of 12.9% over the past 10 years. GuruFocus rated Forest Laboratories Inc. the business predictability rank of 2-star.

New Purchase: Lender Processing Services Inc (LPS)

Joel Greenblatt initiated holdings in Lender Processing Services Inc. His purchase prices were between $26.39 and $31.72, with an estimated average price of $29.35. The impact to his portfolio due to this purchase was 1.58%. His holdings were 163,471 shares as of 12/31/2010.

LENDER PROCESSING SERVICES, INC. is a provider of integrated technology and services to the mortgage industry. Lender Processing Services Inc has a market cap of $3.04 billion; its shares were traded at around $33.27 with a P/E ratio of 9.5 and P/S ratio of 1.2. The dividend yield of Lender Processing Services Inc stocks is 1.2%.

New Purchase: Viropharma Inc. (VPHM)

Joel Greenblatt initiated holdings in Viropharma Inc.. His purchase prices were between $14.45 and $18.19, with an estimated average price of $16.43. The impact to his portfolio due to this purchase was 1.53%. His holdings were 269,572 shares as of 12/31/2010.

ViroPharma Incorporated is an international biopharmaceutical company focused on developing and commercializing products for physician specialists or in hospital settings. Viropharma Inc. has a market cap of $1.33 billion; its shares were traded at around $17.02 with a P/E ratio of 12.4 and P/S ratio of 4.3.

New Purchase: Teradyne Inc. (TER)

Joel Greenblatt initiated holdings in Teradyne Inc.. His purchase prices were between $10.92 and $14.39, with an estimated average price of $12.3. The impact to his portfolio due to this purchase was 1.53%. His holdings were 333,938 shares as of 12/31/2010.

Teradyne, Inc. is a manufacturer of automatic test equipment and related software for the electronics and communications industries. Teradyne Inc. has a market cap of $3.43 billion; its shares were traded at around $18.92 with a P/E ratio of 8.5 and P/S ratio of 2.2.

New Purchase: Aeropostale Inc (ARO)

Joel Greenblatt initiated holdings in Aeropostale Inc. His purchase prices were between $22.96 and $27.32, with an estimated average price of $25.12. The impact to his portfolio due to this purchase was 1.51%. His holdings were 186,880 shares as of 12/31/2010.

Aeropostale, Inc. is a mall-based, specialty retailer of casual apparel and accessories, principally targeting fourteen to seventeen year-old young women and men. Aeropostale Inc has a market cap of $2.33 billion; its shares were traded at around $26.53 with a P/E ratio of 10.1 and P/S ratio of 1. Aeropostale Inc had an annual average earning growth of 32.5% over the past 10 years.

New Purchase: Emcor Group Inc. (EME)

Joel Greenblatt initiated holdings in Emcor Group Inc.. His purchase prices were between $24.5 and $29.89, with an estimated average price of $27.04. The impact to his portfolio due to this purchase was 1.45%. His holdings were 152,494 shares as of 12/31/2010.

EMCOR GROUP, INC. conducts its business through subsidiaries, specializes in the design, integration, installation, start-up, testing, operation andmaintenance of complex mechanical and electrical systems. Emcor Group Inc. has a market cap of $2.15 billion; its shares were traded at around $32.41 with a P/E ratio of 16.3 and P/S ratio of 0.4. Emcor Group Inc. had an annual average earning growth of 13.1% over the past 10 years.

New Purchase: Cubist Pharmaceuticals Inc. (CBST)

Joel Greenblatt initiated holdings in Cubist Pharmaceuticals Inc.. His purchase prices were between $20.98 and $25.25, with an estimated average price of $22.9. The impact to his portfolio due to this purchase was 1.45%. His holdings were 206,522 shares as of 12/31/2010.

Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. Cubist Pharmaceuticals Inc. has a market cap of $1.32 billion; its shares were traded at around $22.26 with a P/E ratio of 12.9 and P/S ratio of 2.1.

New Purchase: Raytheon Company (RTN)

Joel Greenblatt initiated holdings in Raytheon Company. His purchase prices were between $44.45 and $48.33, with an estimated average price of $46.44. The impact to his portfolio due to this purchase was 1.44%. His holdings were 94,876 shares as of 12/31/2010.

Raytheon Company is a global technology company. The company providesproducts and services in the areas of defense and commercial electronics,engineering and construction, and business and special mission aircraft. Raytheon Company has a market cap of $18.77 billion; its shares were traded at around $51.5 with a P/E ratio of 9.7 and P/S ratio of 0.7. The dividend yield of Raytheon Company stocks is 3%. Raytheon Company had an annual average earning growth of 13.7% over the past 10 years.

New Purchase: Apollo Group Inc. (APOL)

Joel Greenblatt initiated holdings in Apollo Group Inc.. His purchase prices were between $34 and $50.49, with an estimated average price of $38.66. The impact to his portfolio due to this purchase was 1.38%. His holdings were 106,618 shares as of 12/31/2010.

Apollo Group, Inc. has been providing higher education to working adults for over 25 years. Apollo Group Inc. has a market cap of $6.23 billion; its shares were traded at around $43.64 with a P/E ratio of 7.9 and P/S ratio of 1.3. Apollo Group Inc. had an annual average earning growth of 23.8% over the past 10 years. GuruFocus rated Apollo Group Inc. the business predictability rank of 4-star.

New Purchase: Gt Solar International Inc. (SOLR)

Joel Greenblatt initiated holdings in Gt Solar International Inc.. His purchase prices were between $6.69 and $9.46, with an estimated average price of $8.38. The impact to his portfolio due to this purchase was 1.36%. His holdings were 457,284 shares as of 12/31/2010.

GT SOLAR INTERNATIONAL, INC. is a global provider of specialized manufacturing equipment and services essential for the production of photovoltaic wafers, cells and modules and polysilicon. Gt Solar International Inc. has a market cap of $1.71 billion; its shares were traded at around $11.35 with a P/E ratio of 10.5 and P/S ratio of 3.2.

New Purchase: Mednax Inc (MD)

Joel Greenblatt initiated holdings in Mednax Inc. His purchase prices were between $54.81 and $68.35, with an estimated average price of $61.14. The impact to his portfolio due to this purchase was 1.36%. His holdings were 61,529 shares as of 12/31/2010.

Mednax, Inc., formerly Pediatrix Medical Group, Inc. Mednax Inc has a market cap of $3.1 billion; its shares were traded at around $64.95 with a P/E ratio of 16.1 and P/S ratio of 2.2. Mednax Inc had an annual average earning growth of 18.6% over the past 10 years. GuruFocus rated Mednax Inc the business predictability rank of 5-star.

New Purchase: Reynolds American Inc. (RAI)

Joel Greenblatt initiated holdings in Reynolds American Inc.. His purchase prices were between $29.245 and $33.4, with an estimated average price of $31.81. The impact to his portfolio due to this purchase was 1.3%. His holdings were 121,995 shares as of 12/31/2010.

Reynolds American Inc. is the parent company of R.J. Reynolds American Inc. has a market cap of $20.05 billion; its shares were traded at around $34.38 with a P/E ratio of 13.8 and P/S ratio of 2.3. The dividend yield of Reynolds American Inc. stocks is 5.7%.

New Purchase: Neustar Inc. (NSR)

Joel Greenblatt initiated holdings in Neustar Inc.. His purchase prices were between $23.98 and $27, with an estimated average price of $25.83. The impact to his portfolio due to this purchase was 1.28%. His holdings were 150,096 shares as of 12/31/2010.

NeuStar is a provider of essential clearinghouse services to the North American communications industry and Internet service providers around the world. Neustar Inc. has a market cap of $1.99 billion; its shares were traded at around $26.95 with a P/E ratio of 18 and P/S ratio of 3.7. Neustar Inc. had an annual average earning growth of 14.5% over the past 5 years.

New Purchase: Veeco Instruments Inc. (VECO)

Joel Greenblatt initiated holdings in Veeco Instruments Inc.. His purchase prices were between $33.71 and $49.97, with an estimated average price of $41.87. The impact to his portfolio due to this purchase was 1.23%. His holdings were 87,488 shares as of 12/31/2010.

VEECO INSTRUMENTS INC. (DE) designs, manufactures, markets and services a broad line of precision beam etching and surface measurement systems used in the manufacture of microelectronic products. Veeco Instruments Inc. has a market cap of $2.1 billion; its shares were traded at around $52.7 with a P/E ratio of 11.9 and P/S ratio of 2.3.

New Purchase: H&r Block Inc. (HRB)

Joel Greenblatt initiated holdings in H&r Block Inc.. His purchase prices were between $10.62 and $14.21, with an estimated average price of $12.44. The impact to his portfolio due to this purchase was 1.15%. His holdings were 295,590 shares as of 12/31/2010.

H&R Block Inc. is a diversified company involved in tax return preparation,electronic filing of income tax returns and other tax-related services. H&r Block Inc. has a market cap of $4.34 billion; its shares were traded at around $14.22 with a P/E ratio of 9.2 and P/S ratio of 1.1. The dividend yield of H&r Block Inc. stocks is 4.2%.

New Purchase: Dell Inc. (DELL)

Joel Greenblatt initiated holdings in Dell Inc.. His purchase prices were between $12.9 and $14.71, with an estimated average price of $13.89. The impact to his portfolio due to this purchase was 1.05%. His holdings were 237,869 shares as of 12/31/2010.

Dell Inc. is a premier provider of products and services required for customers worldwide to build their information-technology and Internet infrastructures. Dell Inc. has a market cap of $29.61 billion; its shares were traded at around $15.34 with a P/E ratio of 11.3 and P/S ratio of 0.6. Dell Inc. had an annual average earning growth of 4.1% over the past 10 years.

New Purchase: Garmin Ltd. (GRMN)

Joel Greenblatt initiated holdings in Garmin Ltd.. His purchase prices were between $28.52 and $34, with an estimated average price of $30.75. The impact to his portfolio due to this purchase was 1.04%. His holdings were 102,852 shares as of 12/31/2010.

Garmin International is designs, manufactures, and markets navigation and communications equipment for a variety of markets, including aviation, marine, automotive, cellular, OEM, and general recreation. Garmin Ltd. has a market cap of $6.47 billion; its shares were traded at around $33.43 with a P/E ratio of 10 and P/S ratio of 2.2. The dividend yield of Garmin Ltd. stocks is 4.4%. Garmin Ltd. had an annual average earning growth of 28.2% over the past 10 years. GuruFocus rated Garmin Ltd. the business predictability rank of 4.5-star.

New Purchase: Accenture Plc (ACN)

Joel Greenblatt initiated holdings in Accenture Plc. His purchase prices were between $43.32 and $50.32, with an estimated average price of $45.51. The impact to his portfolio due to this purchase was 0.97%. His holdings were 61,263 shares as of 12/31/2010.

Accenture Plc is a management consulting, technology services and outsourcing organization. Accenture Plc has a market cap of $34.62 billion; its shares were traded at around $54.04 with a P/E ratio of 19.3 and P/S ratio of 1.5. The dividend yield of Accenture Plc stocks is 1.7%. Accenture Plc had an annual average earning growth of 16.2% over the past 10 years. GuruFocus rated Accenture Plc the business predictability rank of 3-star.

New Purchase: Gilead Sciences Inc. (GILD)

Joel Greenblatt initiated holdings in Gilead Sciences Inc.. His purchase prices were between $35.36 and $40.33, with an estimated average price of $37.6. The impact to his portfolio due to this purchase was 0.91%. His holdings were 76,337 shares as of 12/31/2010.

Gilead Sciences, Inc. is an independent biopharmaceutical company that seeks to provide accelerated solutions for patients and the people who care for them. Gilead Sciences Inc. has a market cap of $31.9 billion; its shares were traded at around $39.29 with a P/E ratio of 11.2 and P/S ratio of 4.3. Gilead Sciences Inc. had an annual average earning growth of 31.4% over the past 5 years.

New Purchase: Gamestop Corp (GME)

Joel Greenblatt initiated holdings in Gamestop Corp. His purchase prices were between $18.27 and $22.95, with an estimated average price of $20.47. The impact to his portfolio due to this purchase was 0.91%. His holdings were 122,175 shares as of 12/31/2010.

GameStop Corp. is the world's largest video game and entertainment software retailer. Gamestop Corp has a market cap of $3.04 billion; its shares were traded at around $20.11 with a P/E ratio of 8.3 and P/S ratio of 0.3. Gamestop Corp had an annual average earning growth of 18.4% over the past 10 years.

New Purchase: Aol Inc. (AOL)

Joel Greenblatt initiated holdings in Aol Inc.. His purchase prices were between $23.96 and $27.16, with an estimated average price of $25.16. The impact to his portfolio due to this purchase was 0.89%. His holdings were 114,978 shares as of 12/31/2010.

AOL Inc. is a global Web services company with an extensive suite of brands and offerings and a substantial worldwide audience. Aol Inc. has a market cap of $2.35 billion; its shares were traded at around $22.04 with a P/E ratio of 8.1 and P/S ratio of 1.

New Purchase: Research In Motion Ltd. (RIMM)

Joel Greenblatt initiated holdings in Research In Motion Ltd.. His purchase prices were between $47.3 and $63.3275, with an estimated average price of $56.13. The impact to his portfolio due to this purchase was 0.77%. His holdings were 40,535 shares as of 12/31/2010.

RESEARCH IN MOTION is a world leader in the mobile communications market and has a history of developing breakthrough wireless solutions. Research In Motion Ltd. has a market cap of $36.48 billion; its shares were traded at around $69.69 with a P/E ratio of 11.9 and P/S ratio of 2.4. Research In Motion Ltd. had an annual average earning growth of 55% over the past 5 years.

New Purchase: Sohu.com Inc. (SOHU)

Joel Greenblatt initiated holdings in Sohu.com Inc.. His purchase prices were between $58.45 and $80.32, with an estimated average price of $69.19. The impact to his portfolio due to this purchase was 0.75%. His holdings were 36,206 shares as of 12/31/2010.

Sohu.com Inc. is a Internet portal in China in terms of brand recognition, page views and registered users. Sohu.com Inc. has a market cap of $3.22 billion; its shares were traded at around $84.91 with a P/E ratio of 23.1 and P/S ratio of 5.2. Sohu.com Inc. had an annual average earning growth of 67.7% over the past 5 years.

New Purchase: Endo Pharmaceuticals Holdings Inc. (ENDP)

Joel Greenblatt initiated holdings in Endo Pharmaceuticals Holdings Inc.. His purchase prices were between $33.14 and $37.13, with an estimated average price of $35.66. The impact to his portfolio due to this purchase was 0.75%. His holdings were 64,565 shares as of 12/31/2010.

Endo Pharmaceuticals Holdings Inc., through its wholly owned subsidiaries, Endo Pharmaceuticals Inc. Endo Pharmaceuticals Holdings Inc. has a market cap of $4.01 billion; its shares were traded at around $34.7 with a P/E ratio of 10.7 and P/S ratio of 2.8. Endo Pharmaceuticals Holdings Inc. had an annual average earning growth of 32.8% over the past 10 years.

New Purchase: Astrazeneca Plc (AZN)

Joel Greenblatt initiated holdings in Astrazeneca Plc. His purchase prices were between $45.8 and $53.5, with an estimated average price of $49.4. The impact to his portfolio due to this purchase was 0.75%. His holdings were 49,550 shares as of 12/31/2010.

AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. Astrazeneca Plc has a market cap of $70.16 billion; its shares were traded at around $49.22 with a P/E ratio of 8.3 and P/S ratio of 2.1. The dividend yield of Astrazeneca Plc stocks is 7.5%. Astrazeneca Plc had an annual average earning growth of 17.6% over the past 10 years. GuruFocus rated Astrazeneca Plc the business predictability rank of 5-star.

New Purchase: The Buckle Inc. (BKE)

Joel Greenblatt initiated holdings in The Buckle Inc.. His purchase prices were between $26.45 and $39.64, with an estimated average price of $34.23. The impact to his portfolio due to this purchase was 0.73%. His holdings were 59,305 shares as of 12/31/2010.

Buckle, Inc. is a retailer of medium to better-priced casual apparel for young men and women. The Buckle Inc. has a market cap of $1.8 billion; its shares were traded at around $38.55 with a P/E ratio of 14.1 and P/S ratio of 1.9. The dividend yield of The Buckle Inc. stocks is 2%. The Buckle Inc. had an annual average earning growth of 18.2% over the past 10 years.

New Purchase: Unisys Corp. (UIS)

Joel Greenblatt initiated holdings in Unisys Corp.. His purchase prices were between $21.51 and $31.2, with an estimated average price of $25.48. The impact to his portfolio due to this purchase was 0.71%. His holdings were 83,741 shares as of 12/31/2010.

Unisys is a worldwide technology services and solutions company. Unisys Corp. has a market cap of $1.75 billion; its shares were traded at around $41.02 with a P/E ratio of 10.3 and P/S ratio of 0.4.

New Purchase: Deckers Outdoor Corp. (DECK)

Joel Greenblatt initiated holdings in Deckers Outdoor Corp.. His purchase prices were between $49.41 and $87.02, with an estimated average price of $66.71. The impact to his portfolio due to this purchase was 0.69%. His holdings were 26,304 shares as of 12/31/2010.

DECKERS OUTDOOR CORP. designs, manufactures, and markets innovative, function-oriented footwear and apparel that have been developed for high-performance outdoor, sports and other lifestyle related activities, as well as for casual use. Deckers Outdoor Corp. has a market cap of $3.49 billion; its shares were traded at around $90.57 with a P/E ratio of 25.9 and P/S ratio of 4.3. Deckers Outdoor Corp. had an annual average earning growth of 20.8% over the past 10 years. GuruFocus rated Deckers Outdoor Corp. the business predictability rank of 2-star.

New Purchase: Nokia Corp. (NOK)

Joel Greenblatt initiated holdings in Nokia Corp.. His purchase prices were between $9.23 and $11.28, with an estimated average price of $10.33. The impact to his portfolio due to this purchase was 0.69%. His holdings were 203,539 shares as of 12/31/2010.

Nokia is the world leader in mobile communications. Nokia Corp. has a market cap of $34 billion; its shares were traded at around $9.08 with a P/E ratio of 11.1 and P/S ratio of 0.6. The dividend yield of Nokia Corp. stocks is 3.9%. Nokia Corp. had an annual average earning growth of 1.2% over the past 10 years.

New Purchase: Weight Watchers International Inc. (WTW)

Joel Greenblatt initiated holdings in Weight Watchers International Inc.. His purchase prices were between $31.28 and $37.57, with an estimated average price of $34.52. The impact to his portfolio due to this purchase was 0.68%. His holdings were 55,804 shares as of 12/31/2010.

Weight Watchers International, Inc. is the largest provider of weight control programs in the world. Weight Watchers International Inc. has a market cap of $4.82 billion; its shares were traded at around $65.39 with a P/E ratio of 25.9 and P/S ratio of 3.3. The dividend yield of Weight Watchers International Inc. stocks is 1.1%. Weight Watchers International Inc. had an annual average earning growth of 12.7% over the past 10 years.

New Purchase: Seagate Technology (STX)

Joel Greenblatt initiated holdings in Seagate Technology. His purchase prices were between $11.48 and $15.92, with an estimated average price of $14.33. The impact to his portfolio due to this purchase was 0.66%. His holdings were 133,815 shares as of 12/31/2010.

Seagate Technology is the worldwide leader in the design, manufacture and marketing of hard disc drives, providing products for a wide-range of applications, including Enterprise, Desktop, Mobile Computing, Consumer Electronics and Branded Solutions. Seagate Technology has a market cap of $6.54 billion; its shares were traded at around $13.86 with a P/E ratio of 5.7 and P/S ratio of 0.6.

New Purchase: Cgi Group Inc. (GIB)

Joel Greenblatt initiated holdings in Cgi Group Inc.. His purchase prices were between $15.05 and $16.98, with an estimated average price of $16.05. The impact to his portfolio due to this purchase was 0.65%. His holdings were 115,663 shares as of 12/31/2010.

CGI provides the full range of IT services including consulting, systems integration and the management of business and IT functions. Cgi Group Inc. has a market cap of $4.77 billion; its shares were traded at around $19.96 with a P/E ratio of 14.5 and P/S ratio of 1.3. Cgi Group Inc. had an annual average earning growth of 20.6% over the past 10 years.

New Purchase: Amedisys Inc (AMED)

Joel Greenblatt initiated holdings in Amedisys Inc. His purchase prices were between $23.47 and $34.25, with an estimated average price of $27.76. The impact to his portfolio due to this purchase was 0.65%. His holdings were 59,637 shares as of 12/31/2010.

Amedisys, Inc. is a multi-regional provider of home health care nursing services. Amedisys Inc has a market cap of $1.1 billion; its shares were traded at around $37.8 with a P/E ratio of 8.1 and P/S ratio of 0.7. Amedisys Inc had an annual average earning growth of 73.5% over the past 10 years.

New Purchase: Glaxosmithkline Plc (GSK)

Joel Greenblatt initiated holdings in Glaxosmithkline Plc. His purchase prices were between $38.28 and $41.86, with an estimated average price of $39.85. The impact to his portfolio due to this purchase was 0.65%. His holdings were 50,826 shares as of 12/31/2010.

GlaxoSmithKline is one of the world's research based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. Glaxosmithkline Plc has a market cap of $100.11 billion; its shares were traded at around $38.55 with a P/E ratio of 13.8 and P/S ratio of 2.2. The dividend yield of Glaxosmithkline Plc stocks is 6.8%. Glaxosmithkline Plc had an annual average earning growth of 6.8% over the past 10 years. GuruFocus rated Glaxosmithkline Plc the business predictability rank of 3-star.

New Purchase: Cephalon Inc. (CEPH)

Joel Greenblatt initiated holdings in Cephalon Inc.. His purchase prices were between $61.5 and $66.86, with an estimated average price of $64.38. The impact to his portfolio due to this purchase was 0.64%. His holdings were 31,505 shares as of 12/31/2010.

Cephalon is an international biopharmaceutical company focused on thediscovery, development and marketing of products to treat sleep disorders,neurological disorders, cancer and pain. Cephalon Inc. has a market cap of $4.4 billion; its shares were traded at around $58.45 with a P/E ratio of 7.2 and P/S ratio of 1.6.

New Purchase: Devry Inc. (DV)

Joel Greenblatt initiated holdings in Devry Inc.. His purchase prices were between $41.72 and $50.96, with an estimated average price of $46.04. The impact to his portfolio due to this purchase was 0.63%. His holdings were 40,261 shares as of 12/31/2010.

DeVry Inc. owns and operates DeVry Institutes of Technology, DenverTechnical College, Keller Graduate School of Management and Becker Conviser CPA Review. Devry Inc. has a market cap of $3.77 billion; its shares were traded at around $53.75 with a P/E ratio of 12.3 and P/S ratio of 1.9. The dividend yield of Devry Inc. stocks is 0.5%. Devry Inc. had an annual average earning growth of 13.9% over the past 10 years.

New Purchase: Altria Group Inc. (MO)

Joel Greenblatt initiated holdings in Altria Group Inc.. His purchase prices were between $23.8 and $26.15, with an estimated average price of $24.79. The impact to his portfolio due to this purchase was 0.62%. His holdings were 77,557 shares as of 12/31/2010.

Altria Group is the parent company of Philip Morris USA, U. Altria Group Inc. has a market cap of $51.63 billion; its shares were traded at around $24.73 with a P/E ratio of 13 and P/S ratio of 2.1. The dividend yield of Altria Group Inc. stocks is 6.1%.

New Purchase: Harris Corp. (HRS)

Joel Greenblatt initiated holdings in Harris Corp.. His purchase prices were between $43.33 and $47.33, with an estimated average price of $45.38. The impact to his portfolio due to this purchase was 0.61%. His holdings were 41,239 shares as of 12/31/2010.

Harris Corporation is an international company focused on communicationsequipment for voice, data and video applications. Harris Corp. has a market cap of $6.22 billion; its shares were traded at around $48.46 with a P/E ratio of 9.8 and P/S ratio of 1.2. The dividend yield of Harris Corp. stocks is 2%. Harris Corp. had an annual average earning growth of 33.1% over the past 10 years. GuruFocus rated Harris Corp. the business predictability rank of 4.5-star.

New Purchase: Arris Group Inc (ARRS)

Joel Greenblatt initiated holdings in Arris Group Inc. His purchase prices were between $9.1 and $11.24, with an estimated average price of $10.19. The impact to his portfolio due to this purchase was 0.6%. His holdings were 162,215 shares as of 12/31/2010.

Arris Group, Inc. is an international communications technology company serving the broadband information transport industries. Arris Group Inc has a market cap of $1.68 billion; its shares were traded at around $13.6 with a P/E ratio of 19.2 and P/S ratio of 1.6. Arris Group Inc had an annual average earning growth of 46.2% over the past 5 years.

New Purchase: Lam Research Corp. (LRCX)

Joel Greenblatt initiated holdings in Lam Research Corp.. His purchase prices were between $39.94 and $52.71, with an estimated average price of $46.72. The impact to his portfolio due to this purchase was 0.6%. His holdings were 35,692 shares as of 12/31/2010.

Lam Research Corporation designs, manufactures, markets and services semiconductor processing equipment used in the fabrication of integrated circuits. Lam Research Corp. has a market cap of $6.76 billion; its shares were traded at around $54.97 with a P/E ratio of 10.4 and P/S ratio of 3.2.

New Purchase: Saic Inc. (SAI)

Joel Greenblatt initiated holdings in Saic Inc.. His purchase prices were between $15.13 and $16.21, with an estimated average price of $15.72. The impact to his portfolio due to this purchase was 0.6%. His holdings were 116,283 shares as of 12/31/2010.

SAIC INC is a scientific, engineering, and technology applications company that uses its deep domain knowledge to solve problems of vital importance to the nation and the world, in national security, energy and the environment, critical infrastructure, and health. Saic Inc. has a market cap of $6.12 billion; its shares were traded at around $16.46 with a P/E ratio of 11.2 and P/S ratio of 0.6.

New Purchase: Amerisourcebergen Corp. (ABC)

Joel Greenblatt initiated holdings in Amerisourcebergen Corp.. His purchase prices were between $30.74 and $34.64, with an estimated average price of $32.1. The impact to his portfolio due to this purchase was 0.58%. His holdings were 51,716 shares as of 12/31/2010.

AmerisourceBergen Corporation is one of the world's largest pharmaceutical services companies serving the United States, Canada and selected global markets. Amerisourcebergen Corp. has a market cap of $10.44 billion; its shares were traded at around $37.43 with a P/E ratio of 16.9 and P/S ratio of 0.1. The dividend yield of Amerisourcebergen Corp. stocks is 1.1%. Amerisourcebergen Corp. had an annual average earning growth of 14.4% over the past 10 years. GuruFocus rated Amerisourcebergen Corp. the business predictability rank of 4.5-star.

New Purchase: Cf Industries Holding Inc. (CF)

Joel Greenblatt initiated holdings in Cf Industries Holding Inc.. His purchase prices were between $94.11 and $136.67, with an estimated average price of $120.36. The impact to his portfolio due to this purchase was 0.55%. His holdings were 12,373 shares as of 12/31/2010.

CF Industries Holdings, Inc. is the holding company for the operations of CF Industries, Inc. Cf Industries Holding Inc. has a market cap of $10.51 billion; its shares were traded at around $147.81 with a P/E ratio of 22.3 and P/S ratio of 4. The dividend yield of Cf Industries Holding Inc. stocks is 0.3%. Cf Industries Holding Inc. had an annual average earning growth of 85.7% over the past 5 years.

New Purchase: Viacom Inc. (VIA.B)

Joel Greenblatt initiated holdings in Viacom Inc.. His purchase prices were between $36.21 and $40.05, with an estimated average price of $38.34. The impact to his portfolio due to this purchase was 0.55%. His holdings were 42,053 shares as of 12/31/2010.

Viacom is a global entertainment content company whose family of prominent and respected brands includes the multiplatform properties of MTV Networks, BET Networks, Paramount Pictures, Paramount Home Entertainment and DreamWorks. Viacom Inc. has a market cap of $25.39 billion; its shares were traded at around $45.65 with a P/E ratio of 16 and P/S ratio of 2.7. The dividend yield of Viacom Inc. stocks is 1.3%. Viacom Inc. had an annual average earning growth of 6.5% over the past 5 years.

New Purchase: Bristolmyers Squibb Co. (BMY)

Joel Greenblatt initiated holdings in Bristolmyers Squibb Co.. His purchase prices were between $25.24 and $27.51, with an estimated average price of $26.5. The impact to his portfolio due to this purchase was 0.55%. His holdings were 63,191 shares as of 12/31/2010.

Bristol-Myers Squibb Company is a global leader in the research and development of innovative lifesaving and life-enhancing treatments for heart disease; high blood pressure; stroke; diabetes; cancer; HIV/AIDS and other infectious diseases; depression, schizophrenia and other mental disorders; pain; and other conditions. Bristolmyers Squibb Co. has a market cap of $44.11 billion; its shares were traded at around $25.77 with a P/E ratio of 11.9 and P/S ratio of 2.2. The dividend yield of Bristolmyers Squibb Co. stocks is 5.2%. Bristolmyers Squibb Co. had an annual average earning growth of 3.3% over the past 5 years.

New Purchase: Mastercard Inc. (MA)

Joel Greenblatt initiated holdings in Mastercard Inc.. His purchase prices were between $217.4 and $259.35, with an estimated average price of $238.18. The impact to his portfolio due to this purchase was 0.51%. His holdings were 7,015 shares as of 12/31/2010.

MASTERCARD INCORPORATED advances global commerce by providing a critical economic link among financial institutions, businesses, cardholders and merchants worldwide. Mastercard Inc. has a market cap of $32.96 billion; its shares were traded at around $251.82 with a P/E ratio of 17.9 and P/S ratio of 5.9. The dividend yield of Mastercard Inc. stocks is 0.2%.

New Purchase: Foster Wheeler Ag (FWLT)

Joel Greenblatt initiated holdings in Foster Wheeler Ag. His purchase prices were between $22.65 and $35, with an estimated average price of $28.22. The impact to his portfolio due to this purchase was 0.46%. His holdings were 41,056 shares as of 12/31/2010.

Foster Wheeler AG, formerly Foster Wheeler Limited, along with its subsidiaries provide construction and engineering services to the oil and gas, oil refining, chemical/petrochemical, pharmaceutical, environmental, and power plant operation and maintenance sectors worldwide. Foster Wheeler Ag has a market cap of $4.92 billion; its shares were traded at around $39.63 with a P/E ratio of 18.8 and P/S ratio of 1.

New Purchase: Mckesson Corp. (MCK)

Joel Greenblatt initiated holdings in Mckesson Corp.. His purchase prices were between $59.88 and $70.97, with an estimated average price of $65.36. The impact to his portfolio due to this purchase was 0.44%. His holdings were 18,977 shares as of 12/31/2010.

McKesson Corporation, the world's largest health care service and technology company, delivers unique supply and information management solutions that reduce costs and improve quality for its health care customers. Mckesson Corp. has a market cap of $20.35 billion; its shares were traded at around $80.42 with a P/E ratio of 17.9 and P/S ratio of 0.2. The dividend yield of Mckesson Corp. stocks is 0.9%. Mckesson Corp. had an annual average earning growth of 18.4% over the past 10 years. GuruFocus rated Mckesson Corp. the business predictability rank of 3-star.

New Purchase: Hewlett Packard Co (HPQ)

Joel Greenblatt initiated holdings in Hewlett Packard Co. His purchase prices were between $40.64 and $44.25, with an estimated average price of $42.41. The impact to his portfolio due to this purchase was 0.42%. His holdings were 30,662 shares as of 12/31/2010.

Hewlett Packard is one of the global providers of computing and imaging solutions and services for business and home. Hewlett Packard Co has a market cap of $106.5 billion; its shares were traded at around $48.62 with a P/E ratio of 10.6 and P/S ratio of 0.8. The dividend yield of Hewlett Packard Co stocks is 0.7%. Hewlett Packard Co had an annual average earning growth of 22.5% over the past 5 years.

About the author:

gurufocus
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 3.9/5 (9 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK